Search Results 651-660 of 14790 for anti-TNF drugs

  1. Peginterferon Alfa-2b (Subcutaneous Route) Precautions - Mayo Clinic

    Using PegIntron® alone or together with ribavirin while you are pregnant can harm your unborn baby. These medicines may also cause birth defects if the ...

  2. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to randomization. - Patients who have received acute, low ...

  3. Nivolumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Nivolumab injection is also used with chemo medicines containing platinum before having surgery for non-small cell lung cancer (NSCLC).

  4. Thalidomide (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Terbinafine (Oral Route) Description and Brand Names - Mayo Clinic

    Terbinafine belongs to the group of medicines called antifungals. It is used to treat fungus infections of the scalp, body, groin (jock itch), feet (athlete's ...

  6. Trastuzumab-Strf (Intravenous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Trastuzumab-strf injection is used together with other cancer medicines (eg, doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, or ...

  7. Antihemophilic Factor (Intravenous Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check you or your child closely while you are ...

  8. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment - Mayo Clinic

    About this study. Drug monitoring of Pembrolizumaband Nivolumab for determining the pharmacokinetic (PK) profile of these medications and to provide ...

  9. Milnacipran (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Targeting VEGF-Independent Proangiogenic Pathways in Anti-VEGF Refractory Renal Cell Cancer - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    Mukhopadhyay's lab is developing novel treatment strategies to target these pathways for refractory and highly aggressive tumor types and for sarcomatoid renal ...